<i>Acinetobacter baumannii</i> Antibiotic Resistance Mechanisms
<i>Acinetobacter baumannii</i> is a Gram-negative ESKAPE microorganism that poses a threat to public health by causing severe and invasive (mostly nosocomial) infections linked with high mortality rates. During the last years, this pathogen displayed multidrug resistance (MDR), mainly du...
Main Authors: | Ioannis Kyriakidis, Eleni Vasileiou, Zoi Dorothea Pana, Athanasios Tragiannidis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/3/373 |
Similar Items
-
In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021-07-01) -
Virulence Characteristics and Emerging Therapies for Biofilm-Forming <i>Acinetobacter baumannii</i>: A Review
by: Karma G. Dolma, et al.
Published: (2022-09-01) -
Antibiotic Resistance and Genotypes of Nosocomial Strains of <i>Acinetobacter baumannii</i> in Kazakhstan
by: Alyona Lavrinenko, et al.
Published: (2021-04-01) -
<i>Acinetobacter baumannii</i> Resistance: A Real Challenge for Clinicians
by: Rosalino Vázquez-López, et al.
Published: (2020-04-01) -
Effect of Phenylalanine–Arginine Beta-Naphthylamide on the Values of Minimum Inhibitory Concentration of Quinolones and Aminoglycosides in Clinical Isolates of <i>Acinetobacter baumannii</i>
by: Stefany Plasencia-Rebata, et al.
Published: (2023-06-01)